PitchSend

Investor Presentaiton

CALIFORNIA PROPOSITION 65: BACKGROUND (CONTINUED) REGULATORY BENCHMARKS -- REPRO/DEVELOPMENTAL: The MADL is developed from dose-response (animal studies). The "Point of Departure" for the risk assessment is the No- Observed-Adverse-Effect-Level (NOAEL). The MADL is the NOAEL divided by a 1000-fold Safety Factor. 6

View entire presentation